Search Results for keywords:"nonclinical testing methods"

Search Results: keywords:"nonclinical testing methods"

S. 5046 — An Act To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
December 12, 2024
Status:Engrossed in Senate
Congress:118
Words:804
S. 5046, also known as the “FDA Modernization Act 3.0,” is a bill that requires the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, to issue new regulations about nonclinical testing methods. This legislation mandates an interim final rule...
Simple Explanation
The FDA Modernization Act 3.0 is a new law that asks for rules to be made so that scientists can use new ways instead of animal testing to check if medicines are safe, but it might be confusing and cost money without telling everyone how much.
S. 5046 — To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
September 12, 2024
Status:Introduced in Senate
Congress:118
Words:353
S. 5046 is a bill that requires the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, to issue a final rule regarding nonclinical testing methods. This bill, also known as the "FDA Modernization Act 3.0," mandates that the rule be published...
Simple Explanation
The bill says that a big boss in charge of health and medicine has to make new rules about how they test medicines without using people or animals, and they need to do it in six months. It also wants to fix a mistake where two parts of the same important book about medicines have the same name.
H. R. 7248 — To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.
February 06, 2024
Status:Introduced in House
Congress:118
Words:2,101
H.R. 7248, also known as the “FDA Modernization Act 3.0,” aims to amend the Federal Food, Drug, and Cosmetic Act to improve nonclinical testing methods for drugs. The bill's goal is to establish a process for qualifying nonclinical testing methods that reduce or replace the...
Simple Explanation
H.R. 7248 is like a plan to find better ways to test if medicine is safe without using so many animals, making the process quicker and better for everyone.

Showing 1 to 3 of 3 results